...
首页> 外文期刊>Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences >Effects of Danhong injection, a traditional Chinese medicine, on nine cytochrome P450 isoforms in vitro in vitro
【24h】

Effects of Danhong injection, a traditional Chinese medicine, on nine cytochrome P450 isoforms in vitro in vitro

机译:中药丹红注射液对九种细胞色素P450体外体外疗效的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Danhong injection (DHI) is made from Salvia miltiorrhiza Bunge. and Carthamus tinctorius L. extract and is widely used in the clinical treatment of cardiovascular and cerebrovascular diseases. This study aimed to evaluate the effect of DHI on cytochrome P450 (CYP450) enzymes in vitro to predict drug–drug interactions based on CYP450 as combination therapy. To assess the inhibitory effect of DHI on CYP450, we detected the IC 50 value of DHI on CYP450 in vitro by liquid chromatography/tandem mass spectrometry (LC–MS/MS). Simultaneously, the induction effect of DHI on CYP450s was also evaluated. The relative induction ratios of DHI on CYP1A2, CYP2B6 and CYP3A4 activity were calculated by LC–MS/MS. The expression level of CYP3A4 mRNA was determined by reverse transcription PCR (RT‐PCR). The LC–MS/MS data showed DHI intensively inhibit CYP2A6 activity and the intensity of inhibition was followed by CYP2C8, CYP3A4, CYP2C19, CYP2B6, CYP2D6, CYP1A2, CYP2E1 and CYP2C9 in vitro . The results of RT‐PCR showed that there is a certain induction of DHI on CYP3A4 mRNA in human primary hepatocytes in vitro . The study suggested that drug–drug interactions might occur in clinical co‐administration of drugs owing to the CYP2A6 inhibition and CYP3A4 induction.
机译:摘要丹红注射(DHI)由Salvia Miltiorrhiza Bunge制成。和Carthamus Tinctorius L.提取物,广泛应用于心血管和脑血管疾病的临床治疗。该研究旨在评估DHI对体育中的效果对体外的细胞色素P450(CYP450)酶的影响,以基于CYP450预测药物 - 药物相互作用作为联合治疗。为了评估DHI对CYP450的抑制作用,通过液相色谱/串联质谱(LC-MS / MS)在体外检测DHI对CYP450的IC 50值。同时,还评估了DHI对CYP450S的诱导效应。通过LC-MS / MS计算DHI对CYP1A2,CYP2B6和CYP3A4活性的相对诱导比。通过逆转录PCR(RT-PCR)测定CYP3A4 mRNA的表达水平。 LC-MS / MS数据显示DHI强烈抑制CYP2A6活性,并且在体外,CYP2C8,CYP3A4,CYP2C19,CYP2B6,CYP2D6,CYP1A2,CYP2E1和CYP2C9的抑制强度。 RT-PCR的结果表明,体外肝细胞中CYP3A4 mRNA的一定诱导DHI。该研究表明,由于CYP2A6抑制和CYP3A4诱导,药物 - 药物相互作用可能发生在药物的临床共同施用中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号